Literature DB >> 33595211

The Effect of the COVID-19 Outbreak on Trauma-Related Visits to a Tertiary Hospital Emergency Department.

Mordehay Cordoba1,2, Roi Anteby1,2, Yaniv Zager1,2, Yiftach Barash1,3,4, Eyal Klang1,3,4, Roy Nadler1,2, Imri Amiel1,2, Mordechai Gutman1,2, Nir Horesh1,2, Nimrod Aviran1,5, Yoram Klein1,5.   

Abstract

BACKGROUND: The novel coronavirus disease (COVID-19) pandemic changed medical environments worldwide.
OBJECTIVES: To evaluate the impact of the COVID-19 pandemic on trauma-related visits to the emergency department (ED).
METHODS: A single tertiary center retrospective study was conducted that compared ED attendance of patients with injury-related morbidity between March 2020 (COVID-19 outbreak) and pre-COVID-19 periods: February 2020 and the same 2 months in 2018 and 2019.
RESULTS: Overall, 6513 patients were included in the study. During the COVID-19 outbreak, the daily number of patients visiting the ED for acute trauma declined by 40% compared to the average in previous months (P < 0.01). A strong negative correlation was found between the number of trauma-related ED visits and the log number of confirmed cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in Israel (Pearson's r = -0.63, P < 0.01). In the COVID-19 period there was a significant change in the proportion of elderly patients (7% increase, P = 0.002), admissions ratio (12% increase, P < 0.001), and patients brought by emergency medical services (10% increase, P < 0.001). The number of motor vehicle accident related injury declined by 45% (P < 0.01).
CONCLUSIONS: A significant reduction in the number of trauma patients presenting to the ED occurred during the COVID-19 pandemic, yet trauma-related admissions were on the rise.

Entities:  

Year:  2021        PMID: 33595211

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  1 in total

1.  The impact of COVID-19 pandemic lockdown on the incidence and outcome of complicated appendicitis.

Authors:  Yaron Rudnicki; Hagai Soback; Ori Mekiten; Guy Lifshiz; Shmuel Avital
Journal:  Surg Endosc       Date:  2021-07-26       Impact factor: 3.453

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.